SCHEMBL31734798

SCHEMBL31734798

O=S1(=O)N=C(NC2CC(F)(F)C2)Nc2ccc(Cl)cc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC8 Q09428 3/20 0.51
KCNJ11 Q14654 3/20 0.51
ALDH1A1 P00352 2/20 0.51
CYP1A2 P05177 2/20 0.51
LMNA P02545 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
THRB P10828 1/20 0.51
TSHR P16473 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
TAAR1 Q96RJ0 1/20 0.37
CXCR2 P25025 5/20 0.35
KDM4E B2RXH2 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL718487 0.87 ABCC8 (0.56) ABCC8KCNJ11ALDH1A1CYP1A2LMNA
SCHEMBL24050507 0.85 ABCC8 (0.53) ABCC8KCNJ11ALDH1A1CYP1A2LMNA
SCHEMBL6555285 0.85 ABCC8 (0.53) ABCC8KCNJ11ALDH1A1CYP1A2LMNA
SCHEMBL31734795 0.84 ALDH1A1 (0.33) ABCC8KCNJ11ALDH1A1CYP1A2LMNA
SCHEMBL717798 0.84 ABCC8 (0.52) ABCC8KCNJ11ALDH1A1CYP1A2LMNA
SCHEMBL31734762 0.80 ABCC8 (0.48) ABCC8KCNJ11ALDH1A1CYP1A2LMNA
SCHEMBL31734796 0.79 ABCC8 (0.55) ABCC8KCNJ11ALDH1A1CYP1A2LMNA
SCHEMBL718174 0.78 ABCC8 (0.44) ABCC8KCNJ11ALDH1A1CYP1A2LMNA
SCHEMBL6553120 0.76 ABCC8 (0.48) ABCC8KCNJ11ALDH1A1CYP1A2LMNA
SCHEMBL24050255 0.76 ABCC8 (0.45) ABCC8KCNJ11ALDH1A1CYP1A2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250360142-A1 NOVEL ATP-SENSITIVE POTASSIUM CHANNEL POTENTIATORS, THEIR PREPARATION AND USE RHYTHM PHARMACEUTICALS INC (US) 2025-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250360142-A1 NOVEL ATP-SENSITIVE POTASSIUM CHANNEL POTENTIATORS, THEIR PREPARATION AND USE KCNJ11, ATP1A2, ATP1A3 ABCC8 95/4885KCNJ11 1/4885ALDH1A1 2043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.